SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-021040
Filing Date
2024-04-22
Accepted
2024-04-22 16:37:34
Documents
5
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20024160x3_def14a.htm DEF 14A 692580
2 logo_appliedtherapeutics.jpg GRAPHIC 31301
3 ny20024160x3-pc_1.jpg GRAPHIC 582990
4 ny20024160x3-pc_2.jpg GRAPHIC 553111
5 sig_shoshanashendelman.jpg GRAPHIC 16900
  Complete submission text file 0001140361-24-021040.txt   2323931
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38898 | Film No.: 24861654
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)